[Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
Serfaty
Lawrence
L
Service d'Hépato-gastroentérologie, Hôpital Saint-Antoine, Paris.
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004796:Clinical Enzyme Tests; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D000637:Transaminases / Q000097:blood*; D019562:Viral Load
D000998:Antiviral Agents; D012367:RNA, Viral; D012254:Ribavirin; D007372:Interferons; D000637:Transaminases